Ontology highlight
ABSTRACT:
SUBMITTER: Combe P
PROVIDER: S-EPMC4485845 | biostudies-literature | 2015 May
REPOSITORIES: biostudies-literature
Combe Pierre P de Guillebon Eleonore E Thibault Constance C Granier Clémence C Tartour Eric E Oudard Stéphane S
Oncoimmunology 20150319 5
Despite the renaissance of cancer immunotherapy, no novel immunotherapy has been approved for the treatment of renal cell cancer (RCC) since the availability of recombinant cytokines (interleukin-2, interferon-α). All vaccine trials have failed to meet their endpoints although they have highlighted potential predictive biomarkers (e.g., pre-existing immune response, hematological parameters, tumor burden). Recent advances in immunomodulatory therapies have prompted the study of combination treat ...[more]